DUBLIN--(BUSINESS WIRE)--The "Global Sickle Cell Disease Clinical Trial Pipeline Highlights - 2020" report has been added to ResearchAndMarkets.com's offering.
This report provides the most up-to-date information on key pipeline products in the global Sickle Cell Disease market. It covers emerging therapies for Sickle Cell Disease in active clinical development stages including early and late-stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Sickle Cell Disease pipeline products by clinical trial stages including both early and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Sickle Cell Disease pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides Sickle Cell Disease pipeline products by company.
Short-term Launch Highlights:
Find out which Sickle Cell Disease pipeline products will be launched in the US and beyond to 2025.
Key Topics Covered:
1. Sickle Cell Disease Pipeline by Stages
2. Sickle Cell Disease Phase 3 Clinical Trial Insights
3. Sickle Cell Disease Phase 2 Clinical Trial Insights
4. Sickle Cell Disease Phase 1 Clinical Trial Insights
5. Sickle Cell Disease Preclinical Research Insights
6. Sickle Cell Disease Discovery Stage Insights
7. Appendix
8. Research Methodology
List of Tables
Table 1: Sickle Cell Disease Phase 3 Clinical Trials, 2020
Table 2: Sickle Cell Disease Phase 2 Clinical Trials, 2020
Table 3: Sickle Cell Disease Phase 1 Clinical Trials, 2020
Table 4: Sickle Cell Disease Preclinical Research, 2020
Table 5: Sickle Cell Disease Discovery Stage, 2020
List of Figures
Figure 1: Sickle Cell Disease Pipeline Molecules by Clinical Trials Stage, 2020
Figure 2: Sickle Cell Disease Phase 3 Clinical Trial Highlights, 2020
Figure 3: Sickle Cell Disease Phase 2 Clinical Trial Highlights, 2020
Figure 4: Sickle Cell Disease Phase 1 Clinical Trial Highlights, 2020
Figure 5: Sickle Cell Disease Preclinical Research Highlights, 2020
Figure 6: Sickle Cell Disease Discovery Stage Highlights, 2020
For more information about this report visit https://www.researchandmarkets.com/r/q8oym9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
